Shandong Keyuan Pharmaceutical Co Ltd banner
S

Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281

Watchlist Manager
Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
Watchlist
Price: 38.24 CNY -1.47%
Market Cap: ¥2.7B

Shandong Keyuan Pharmaceutical Co Ltd
Non-Reccuring Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Shandong Keyuan Pharmaceutical Co Ltd
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
Non-Reccuring Items
-¥1.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Non-Reccuring Items
¥4.3m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Non-Reccuring Items
-¥70m
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Non-Reccuring Items
¥1.9m
CAGR 3-Years
N/A
CAGR 5-Years
-32%
CAGR 10-Years
-12%
Zhejiang Nhu Co Ltd
SZSE:002001
Non-Reccuring Items
-¥19.3m
CAGR 3-Years
36%
CAGR 5-Years
13%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Non-Reccuring Items
-¥400
CAGR 3-Years
N/A
CAGR 5-Years
71%
CAGR 10-Years
N/A
No Stocks Found

Shandong Keyuan Pharmaceutical Co Ltd
Glance View

Market Cap
2.7B CNY
Industry
Pharmaceuticals

Shandong Keyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical raw materials, and chemical preparation. The company is headquartered in Jinan, Shandong. The company went IPO on 2023-04-04. The firm's main products include gliclazide, metformin hydrochloride, ropivacaine hydrochloride and others. The firm's products are used in hypoglycemic, anesthetic, cardiovascular and psychiatric diseases. The firm conducts its operations mainly in the domestic market.

Intrinsic Value
21.63 CNY
Overvaluation 43%
Intrinsic Value
Price ¥38.24
S

See Also

What is Shandong Keyuan Pharmaceutical Co Ltd's Non-Reccuring Items?
Non-Reccuring Items
-1.7m CNY

Based on the financial report for Dec 31, 2025, Shandong Keyuan Pharmaceutical Co Ltd's Non-Reccuring Items amounts to -1.7m CNY.

What is Shandong Keyuan Pharmaceutical Co Ltd's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 1Y
-2 641%

Over the last year, the Non-Reccuring Items growth was -2 641%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett